Health Bulletin 11/September/2023
Here are the top health stories for the day:
NEET PG in March 2024? NMC draft regulations spark speculations
With the National Medical Commission (NMC) releasing the draft Post-Graduate Medical Education Regulations (PGMER) 2023, there are speculations that the National Eligibility-cum-Entrance Test Postgraduate (NEET PG) examination will be conducted in March 2024.
This comes as the NMC in its draft regulations stated that the common centralized entrance examination for Postgraduate courses for PG medical admissions next year will be conducted in the month of March.
For more details, check out the link given below:
NEET PG In March 2024? NMC Draft Regulations Spark Speculations
DCGI urges states to monitor sale of counterfeit drugs after WHO alerts
Drugs Controller General of India (DCGI) instructed all the drug control authorities of all states and union territories to keep a strict watch on the sale and distribution of counterfeit versions of two drugs, Defitelio for liver treatment and Adcetris for cancer, following alerts from the World Health Organisation (WHO).
Doctors measure blood pressure wrongly, says report
Over half of patients with uncontrolled high blood pressure achieved controlled blood pressure measurements after participating in a remote digital monitoring program, according to new research to be presented at the American Heart Association’s Hypertension Scientific Sessions 2023, held Sept. 7-10, 2023, in Boston. The meeting is the premier scientific exchange focused on recent advances in basic and clinical research on high blood pressure and its relationship to cardiac and kidney disease, stroke, obesity and genetics.
“Although medication to treat hypertension is effective, blood pressure has been historically challenging to control because patients need to make significant lifestyle and behavioral changes, too,” said lead study author Irina Yermilov, M.D., M.P.H., M.S., chief medical officer of CAREMINDr.
Reference: 1 in 2 patients had better blood pressure control after using remote, bilingual program, American Heart Association, AHA Hypertension Scientific Sessions 2023
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.